The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
Recruiting
Observational Study
Lipoprotein Disorder
Arterial Stiffness
Endothelial Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- University of Athens · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
1. Introduction Lipoprotein(a), or Lp(a), is a type of lipoprotein that is structurally similar to LDL (low-density lipoprotein) but carries an additional protein called apolipoprotein (a).
2. Purpose of the Study
The primary purpose of this study is to investigate the effect of Lp(a) levels on arterial stiffness, endothelial function, and left atrial (LA) and left ventricular (LV) deformation…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults participants 18-75 years old
* Willing to sign the informed consent and paerticipate in the study
Exclusion Criteria:
* History of autoimmune/autoinflammatory disease,
* Severe valvular heart disease,
* severe chronic kidney disease(eGFR\<60 ml/min/1.73 m2),
* Active …
Contacts